High-dose tamoxifen in high-hormone-receptor-expressing advanced breast cancer patients: a phase II pilot study

BACKGROUND: Tumor progression following endocrine therapy is considered to indicate resistance to endocrine drugs due to a variety of mechanisms. An insufficient dose of endocrine drugs is one of the causes for treatment failure in some patients with high hormone-receptor (HR)-expressing advanced br...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Yanhong, Zhang, Yarui, Hua, Xin, Huang, Jiajia, Bi, Xiwen, Xia, Wen, Wang, Xinyue, Huang, Zhangzan, Song, Chenge, Zhong, Yongyi, Shi, Yanxia, Wang, Shusen, Fan, Wei, Yuan, Zhongyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934038/
https://www.ncbi.nlm.nih.gov/pubmed/33737962
http://dx.doi.org/10.1177/1758835921993436

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7934038/
https://www.ncbi.nlm.nih.gov/pubmed/33737962
http://dx.doi.org/10.1177/1758835921993436

Ejemplares similares